Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy ; volume:11 ; number:6 ; day:30 ; month:4 ; year:2020 ; pages:1397-1406 ; date:6.2020
Diabetes therapy ; 11, Heft 6 (30.4.2020), 1397-1406, 6.2020
- Urheber
-
Guan, Jian
Cai, Na
Liu, Li-Min
Zhao, Ning
Liu, Ning-ning
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-020-00822-0
- URN
-
urn:nbn:de:101:1-2020080220054807907280
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guan, Jian
- Cai, Na
- Liu, Li-Min
- Zhao, Ning
- Liu, Ning-ning
- SpringerLink (Online service)
Ähnliche Objekte (12)
Refining vitrectomy for proliferative diabetic retinopathy
Post-vitrectomy delayed retinal breaks in proliferative diabetic retinopathy
Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients
Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage
Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients
Small-Gauge Vitrectomy for Diabetic Retinopathy
Influencing factors of low vision 2 years after vitrectomy for proliferative diabetic retinopathy: an observational study
Incidence and risk factor analysis of neovascular glaucoma following vitrectomy in patients with proliferative diabetic retinopathy
Topical insulin in neurotrophic keratopathy after diabetic vitrectomy
A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy
Refining vitrectomy for proliferative diabetic retinopathy
Post-vitrectomy delayed retinal breaks in proliferative diabetic retinopathy
Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients
Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage
Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients
Small-Gauge Vitrectomy for Diabetic Retinopathy
Influencing factors of low vision 2 years after vitrectomy for proliferative diabetic retinopathy: an observational study
Incidence and risk factor analysis of neovascular glaucoma following vitrectomy in patients with proliferative diabetic retinopathy
Topical insulin in neurotrophic keratopathy after diabetic vitrectomy
A pilot study of viscoelastic agent to prevent recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy
Refining vitrectomy for proliferative diabetic retinopathy
Post-vitrectomy delayed retinal breaks in proliferative diabetic retinopathy
Prospective Comparison of Surgery Outcome Between Preoperative and Intraoperative Intravitreal Injection of Ranibizumab for Vitrectomy in Proliferative Diabetic Retinopathy Patients
Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage
Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients
Small-Gauge Vitrectomy for Diabetic Retinopathy
Influencing factors of low vision 2 years after vitrectomy for proliferative diabetic retinopathy: an observational study
Incidence and risk factor analysis of neovascular glaucoma following vitrectomy in patients with proliferative diabetic retinopathy
Topical insulin in neurotrophic keratopathy after diabetic vitrectomy